EPAM Q3 revenue rises 1.3% to $1.168 billion; raises full-year EPS outlook
EPAM reported third-quarter 2024 revenue of $1.168 billion, up 1.3% year over year, and GAAP diluted EPS of $2.37, up 43.6%. The company raised its full-year GAAP and non-GAAP diluted EPS ranges, but it said the quarter included a $52.0 million benefit from Polish R&D incentives, and organic constant currency revenue fell 0.3%.
Key points
- Q3 revenue $1.168 billion, up 1.3% year over year; organic constant currency revenue down 0.3%
- GAAP diluted EPS $2.37, up from $1.65; non-GAAP diluted EPS $3.12, up 14.3% from $2.73
- Q3 included a $52.0 million Poland R&D incentive benefit, of which $22.9 million related to 2023 activities
- Full-year GAAP diluted EPS now $7.78 to $7.86; Q4 revenue expected $1.205 billion to $1.215 billion
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:17 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 06, 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.